Publications

Leighton JK, Brown P, Ellis A, Harlow P, Harrouk W, Pine PS, Robison T, Rosario L, Thompson K. 2006. Workgroup Report: Review of genomic data based on experience with mock submissions: View of the CDER Pharmacology Toxicology Nonclinical Pharmacogenomics Subcommittee. Environ Health Perspect 114:573-578; doi: 10.1289/ehp.8318.

Staskal DF, Diliberto JJ, Birnbam LS. 2006. Disposition of BDE 47 in developing mice. Toxicol Sci 90(2):309-16; doi: 10.1093/toxsci/kfj098. PMID: 16407092.

Jackson MA, Lea I, Rashid A, Peddada SD, Dunnick JK. 2006. Genetic alterations in cancer knowledge system: Analysis of gene mutations in mouse and human liver and lung tumors. Toxicol Sci 90(2):400–418; doi: 10.1093/toxsci/kfj101. PMID: 16410370.

Mezei G, Cher D, Kelsh M, Edinboro C, Chapman P, Kavet R. 2005. Occupational magnetic field exposure, cardiovascular disease mortality, and potential confounding by smoking. Ann Epidemiol 15(8):622–629; doi: 10.1016/j.annepidem.2004.12.013.

Niple JC, Sahl JD, Kelsh MA, Kavet R. 2005. Equipment grounding affects contact current exposure: A case study of sewing machines. Ann Occup Hyg 49(8):673–682; doi: 10.1093/annhyg/mei031.

Staskal DF, Diliberto JJ, Birnbaum LS. 2006. Impact of repeated exposure on the toxicokinetics of BDE 47 in mice. Toxicol Sci 89(2):380-5; doi: 10.1093/toxsci/kfj038. PMID: 16280385.

Rose WC, Marathe PH, Jang G, Monticello TM, Balasubramanian BN, Long B, Fairchild C, Wall ME, Wani MC. 2006. Novel fluoro-substituted campthothecins: In vivo antitumor activity, reduced gastrointestinal toxicity and pharmacokinetic characterization. Cancer Chemother Pharmacol 58(1):73-85; doi: 10.1007/s00280-005-0128-y.

Celli BR, Halbert RJ, Nordyke RJ, Schau B. 2005. Airway obstruction in never smokers: Results from the third National Health and Nutrition Examination Survey. Am J Med 118(12):1364-72; doi: 10.1016/j.amjmed.2005.06.041. PMID: 16378780.

Grasty RC, Bjork JA, Wallace KB, Lau CS, Rogers JM. 2005. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res B 74(5):405–416; doi: 10.1002/bdrb.20059. PMID: 6249997.

Ulrich K, Stern M, Goddard ME, Williams J, Zhu J, Dewar A, Painter HA, Jeffery PK, et al. 2005. Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury. Lung Cell Molec Physiol 288(6):L1179-92; doi: 10.1152/ajplung.00450.2004. PMID: 15681392.

Ebeler SE, Dingley KH, Ubick E, Abel S, Mitchell AE, Burns SA, et al. 2005. Animal models and analytical approaches for understanding the relationships between wine and cancer. Drugs Exp Clin Res 31(1):19–27. PMID: 15921026.

Rickert DE, Dingley K, Ubick E, Dix KJ, Molina L. 2005. Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation. Chem Biol Interact 155(1–2):55–61; doi: 10.1016/j.cbi.2005.04.002. PMID: 15893299.

Bailer AJ, Wheeler MW, Dankovic D, Noble R, Bena J. 2005. Incorporating uncertainty and variability in the assessment of occupational hazards. Int J Risk Assess Manage 5(2-4):344-57; doi: 10.1504/IJRAM.2005.007176.

van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, Nonikov D. 2005. Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. Respirology 10(3):323-33; doi: 10.1111/j.1440-1843.2005.00720.x. PMID: 15955145.

Fukuhara S, Nishimura M, Nordyke RJ, Zaher CA, Peabody JW. 2005. Patterns of care for COPD by Japanese physicians. Respirology 10(3):341-8; doi: 10.1111/j.1440-1843.2005.00717.x. PMID: 15955147.

Brown K, Dingley KH, Turteltaub KW. 2005. Accelerator mass spectrometry for biomedical research. Methods Enzymol 402:423–443; doi: 10.1016/S0076-6879(05)02014-8. PMID: 16401518.

Teeguarden JG, Waechter JM Jr, Clewell HJ 3rd, Covington TR, Barton HA. 2005. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding and uterine tissue dose metrics of bisphenol A: A physiologically based pharmacokinetic approach. Toxicol Sci 85(2):429–446; doi: 10.1093/toxsci/kfi135.

Gentry PR, Haber LT, McDonald TB, Zhao Q, Covington T, Nance P, Clewell HJ III, Lipscomb JC, Barton HA. 2005. Data for physiologically based pharmacokinetic modeling in neonatal animals: Physiological parameters in mice and Sprague-Dawley rats. J Children’s Health 2(3–4):363–411; doi: 10.3109/15417060490970430.

Bailer AJ, Noble RB, Wheeler MW. 2005. Model uncertainty and risk estimation for experimental studies of quantal responses. Risk Anal 25(2):291-9; doi: 10.1111/j.1539-6924.2005.00590.x. PMID: 15876205.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. 2005. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol Sci 84(2):225-31; doi: 10.1093/toxsci/kfi090. PMID: 15659567.